Updated On: 08 May, 2024 06:27 PM IST | Mumbai | IANS
The revelation comes amid British-Swedish pharma giant AstraZeneca recalling its Covid-19 vaccine globally after it acknowledged in late April that the vaccine can cause thrombosis as a side-effect

The SII stressed that despite the challenges faced during the global pandemic, the safety of the vaccine remains paramount. Photo Courtesy: AFP
As British-Swedish pharma giant AstraZeneca recalled its Covid-19 vaccine globally, Pune-based Serum Institute of India (SII) on Wednesday said it stopped the manufacturing and supply of additional doses of Covishield in December 2021.
AstraZeneca has voluntarily withdrawn the "marketing authorisation" of its Covid vaccine, sold as Covishield in India and Vaxzevria in Europe.